Sign in
4

Changes in Ownership

Nuvectis Pharma, Inc. Filed Acc 0001104659-22-122887

Chairman & CEO bought 450 shares at an average $7.41 ($3,335)

From the SEC's structured data for this filing

Trades in this filing

BENTSUR RON · Chairman & CEO

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2022-11-25 Purchase : show line 1 in the form +150 $7.38 $1,107 3,015,009 D
2022-11-28 Purchase : show line 2 in the form +150 $7.40 $1,110 3,015,159 D
2022-11-29 Purchase : show line 3 in the form +150 $7.45 $1,118 3,015,309 D
Open-market purchases · 450 sh · avg $7.41 · $3,335
Loading xslF345X03/tm2231558-1_4seq1.xml…